● Education - In-room cameras enable care teams to view side-by-side images along with procedural video for real-time comparison. This enables live procedures and courses to be recorded and reviewed for educational and training purposes- a process that would otherwise be too cumbersome to pursue.
The platform was recently installed at Brigham and Women’s Hospital and is currently being leveraged by clinicians along with the rest of Fujifilm’s endoscopic imaging portfolio, which was purchased and installed earlier this year.
Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs
“Having Fujifilm’s Systems Integration platform in our endoscopy suite has dramatically reduced our procedure times as we no longer have to unplug wires, change system inputs, and worry about images not routing or showing up on the right monitors,” says Dr. Chris Thompson, Director of Endoscopy, Brigham and Women's Hospital. “We have seamless integration of all pertinent patient imaging and data without the hassle, and the time saved means patients spend less time under anesthesia, which is helping us to improve our care delivery.”
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of innovative diagnostic imaging products and medical informatics solutions that meet and exceed the evolving needs of healthcare facilities today and into the future. It’s ever expanding medical imaging solutions span digital radiography (DR), detectors, portables and suites, mammography systems with digital breast tomosynthesis, computed tomography solutions for oncology and radiology applications, technologically advanced flexible and surgical endoscopy and fluoroscopy solutions. Fujifilm enables interoperability through its Systems Integration offering as well as its comprehensive, AI-supported Synapse® Enterprise Imaging portfolio, which includes the TeraMedica Division of Fujifilm. Fujifilm’s in vitro diagnostics (IVD) portfolio includes clinical lab reagents, and biomarkers to assess the risk for the development of hepatocellular carcinoma in patients with chronic liver disease. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions and imaging products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship.Back to HCB News